HT and breast cancer risk

Sexuality, Reproduction and Menopause

Volumn 1, Issue 1, 2003, Pages 15-18

  Geller, Michelle L ^a   Chlebowski, Rowan T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ETHINYLESTRADIOL; PLACEBO; SEX HORMONE; TIBOLONE;

ARTICLE; BREAST CANCER; CANCER CENTER; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER REGISTRY; CANCER RESEARCH; CANCER RISK; CHRONIC DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; FEMALE; HUMAN; MAMMOGRAPHY; MEDICAL INFORMATION; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; RISK REDUCTION; UNITED KINGDOM; UNITED STATES; VASOMOTOR DISORDER;

EID: 13344259909     PISSN: 15462501     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sram.2004.02.019     Document Type: Review

References (8)

1. Collaborative Group on Hormonal Factors in Breast Cancer, Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer, Lancet 350 1997 1047-1059
2. Ross R.K. Paganini-Hill A. Wan P.C. Pike M.C. Effect of hormone replacement therapy on breast cancer risk J Natl Cancer Inst 92 2000 328-332
3. Chen C.L. Weiss N.S. Newcomb P. Barlow W. White E. Hormone replacement therapy in relation to breast cancer JAMA 289 2002 734-741
4. Rossouw E. Anderson G.L. Prentice R.L. et al. for Writing Group for the Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative JAMA 288 2002 321-333
5. Chlebowski R.T. Hendrix S.L. Langer R.D. et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative randomized trial JAMA 289 2003 3243-3253
6. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362;419-27
7. Hays J. Ockene J.K. Brunner R.T. et al. Effects of estrogen plus progestin on health-related quality of life N Engl J Med 348 2003 1839-1854
8. Harvey J.A. et al. Short-term cessation of hormone replacement therapy and improvement of mammographic specificity J Natl Cancer Inst 89 1997 1623-1625